Agile Therapeutics Inc (STU:0AL)
€ 9.83 0 (0%) Market Cap: 7.41 Mil Enterprise Value: 4.63 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 19/100

Agile Therapeutics Inc Extraordinary Shareholders Meeting Transcript

Jan 07, 2022 / 02:00PM GMT
Release Date Price: €770.4 (-0.41%)
Operator

Good morning, and welcome to the Special Meeting of Stockholders of Agile Therapeutics, Inc. I would now like to introduce Al Altomari, Chairman and CEO.

Al Altomari
Agile Therapeutics, Inc. - Chairman, CEO, and Director

Thank you, operator. Good morning, everyone. And welcome to the Special Meeting of Stockholders of Agile Therapeutics, Inc. I'm Al Altomari, the Chairman and Chief Executive Officer. I'll be presiding over this meeting. It's my pleasure to welcome you today. We are hosting a virtual meeting and leveraging technology to be more inclusive and reach a greater number of our stockholders.

Our stockholders are attending via web portal as described in the proxy voting materials. Stockholders may submit questions at any time during the official business portion of the meeting in the space provided on the web portal.

We will conduct the official business of meeting first. During this portion of meeting, all discussions will be limited to the official business at hand. Participants will be limited to stockholders of record and their

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot